Stereotaxis (STXS) Operating Margin (2010 - 2026)
Stereotaxis' (STXS) quarterly Operating Margin came in at 95.07% in Q1 2026, down 1572.0% year-over-year from 6.46% in Q1 2025, and down 45.44% quarter-over-quarter from 65.37% in Q4 2025.
Powered by 
Analysis
Stereotaxis (STXS) Operating Margin (2010 - 2026) Analysis & Trends
Stereotaxis (STXS) has reported Operating Margin for 17 consecutive years, with 95.07% the latest figure, recorded in Q1 2026.
- On a quarterly basis, Operating Margin fell 1572.0% year-over-year to 95.07% in Q1 2026; TTM through Mar 2026 was 71.05%, a 2318.0% increase from a year earlier, with the FY2025 full-year figure at 68.3%, up 2361.0% from the prior year.
- Operating Margin was 95.07% for Q1 2026 at Stereotaxis, down from 65.37% in the prior quarter.
- Over five years, Operating Margin peaked at 45.2% in Q2 2025 and troughed at 133.74% in Q2 2024.
- A 5-year average of 80.92% and a median of 72.3% in 2023 frame the typical range for Operating Margin.
- Across the five-year window, Operating Margin plunged 6659 bps in 2024 and surged 8854 bps in 2025, its largest moves.
- Over 5 years, Operating Margin stood at 61.03% in 2022, then sank by 90 bps to 116.19% in 2023, then retreated by 4 bps to 120.3% in 2024, then jumped by 46 bps to 65.37% in 2025, then plunged by 45 bps to 95.07% in 2026.
- The last three Operating Margin figures came in at 95.07% (Q1 2026), 65.37% (Q4 2025), and 87.85% (Q3 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Operating Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 179.79 Bn | 174.18 Bn | 7.27 Bn | 13.44% |
| 2 | Intuitive Surgical | 127.69 Bn | 122.47 Bn | 1.96 Bn | 33.60% |
| 3 | Medtronic | 117.23 Bn | 108.41 Bn | 6.34 Bn | 18.08% |
| 4 | Stryker | 103.55 Bn | 100.07 Bn | 4.50 Bn | 25.18% |
| 5 | Boston Scientific | 63.24 Bn | 62.70 Bn | 3.85 Bn | 21.65% |
| 6 | Edwards Lifesciences | 49.97 Bn | 45.72 Bn | 1.35 Bn | 29.48% |
| 7 | Alcon | 32.83 Bn | 31.37 Bn | 1.68 Bn | 0.40% |
| 8 | Dexcom | 32.30 Bn | 30.35 Bn | 830.00 Mn | 24.33% |
| 9 | Steris | 20.73 Bn | 20.25 Bn | 684.20 Mn | 19.15% |
| 10 | Stereotaxis | 129.55 Mn | 114.93 Mn | 3.79 Mn | -95.07% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -95.07% |
| Dec 31, 2025 | -65.37% |
| Sep 30, 2025 | -87.85% |
| Jun 30, 2025 | -45.20% |
| Mar 31, 2025 | -79.35% |
| Dec 31, 2024 | -120.30% |
| Sep 30, 2024 | -69.00% |
| Jun 30, 2024 | -133.74% |
| Mar 31, 2024 | -68.98% |
| Dec 31, 2023 | -116.19% |
| Sep 30, 2023 | -72.30% |
| Jun 30, 2023 | -67.15% |
| Mar 31, 2023 | -85.81% |
| Dec 31, 2022 | -61.03% |
| Sep 30, 2022 | -65.98% |
| Jun 30, 2022 | -84.18% |
| Mar 31, 2022 | -58.11% |
| Dec 31, 2021 | -40.64% |
| Sep 30, 2021 | -50.74% |
| Jun 30, 2021 | -37.47% |